Skip to main content
. 2021 Jul 15;94(1125):20210117. doi: 10.1259/bjr.20210117

Table 2.

T.R.U.S.T. criteria indicating a contraindication for primary CRS and triage to neoadjuvant chemotherapy15

- Lymph node enlargement above the renal hilum (larger than 10 mm short axis)
- Tumor involvement of the stomach or duodenum
- Tumor involvement of the pancreas
- Tumor involvement of the celiac trunk, hepatic artery, gastric artery
- Extensive tumor involvement of the mesentery and/or small bowel

CRS, cytoreductive surgery.